Open AccessEuropean Medicines Agency (EMA) announces termination of Avandia (rosiglitazone usage in Europe)
Author(s) -
Инна Игоревна Клефортова,
Клефортова Инна Игоревна
Publication year - 2010
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/2072-0351-5509
Subject(s) - rosiglitazone , medicine , agency (philosophy) , traditional medicine , pharmacology , endocrinology , diabetes mellitus , philosophy , epistemology